BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1689373)

  • 1. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia.
    Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN
    J Neurochem; 1990 Mar; 54(3):1027-33. PubMed ID: 1689373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of profound insulin-induced hypoglycemia on quinolinic acid in hippocampus and plasma.
    Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN
    Adv Exp Med Biol; 1991; 294():679-82. PubMed ID: 1722957
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular levels of quinolinic acid are moderately increased in rat neostriatum following severe insulin-induced hypoglycaemia.
    Westerberg E; Magnusson K; Wieloch T; Ungerstedt U; Speciale C; Schwarcz R
    Acta Physiol Scand; 1990 Mar; 138(3):417-22. PubMed ID: 2139298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats.
    Speciale C; Ungerstedt U; Schwarcz R
    Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil.
    Heyes MP; Nowak TS
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):660-7. PubMed ID: 1696582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading.
    During MJ; Freese A; Heyes MP; Swartz KJ; Markey SP; Roth RH; Martin JB
    FEBS Lett; 1989 Apr; 247(2):438-44. PubMed ID: 2523822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading.
    During MJ; Heyes MP; Freese A; Markey SP; Martin JB; Roth RH
    Brain Res; 1989 Jan; 476(2):384-7. PubMed ID: 2522807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.
    Heyes MP; Markey SP
    Anal Biochem; 1988 Oct; 174(1):349-59. PubMed ID: 2975477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lipopolysaccharide and pokeweed mitogen increase quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Kim P; Markey SP
    J Neurochem; 1988 Dec; 51(6):1946-8. PubMed ID: 2972813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracerebral injections of quinolinic acid on serotonergic neurons in the rat brain.
    Aldinio C; Mazzari S; Toffano G; Köhler C; Schwarcz R
    Brain Res; 1985 Aug; 341(1):57-65. PubMed ID: 2412634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in rat cerebral quinolinic acid concentration following chronic hydrocortisone treatment.
    Connick J; Lombardi G; Beni M; Moroni F
    Neurosci Lett; 1988 May; 88(2):216-20. PubMed ID: 2454438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
    Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.
    Foster AC; Miller LP; Oldendorf WH; Schwarcz R
    Exp Neurol; 1984 May; 84(2):428-40. PubMed ID: 6232146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of excessive tryptophan and its neurometabolites in fatigue.
    Yamamoto T; Azechi H; Board M
    Can J Neurol Sci; 2012 Jan; 39(1):40-7. PubMed ID: 22384494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid.
    Heyes MP; Saito K; Markey SP
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):633-5. PubMed ID: 1534219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Quearry BJ; Markey SP
    Brain Res; 1989 Jul; 491(1):173-9. PubMed ID: 2475209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinic acid stimulates luteinizing hormone secretion in female rats: evidence for involvement of N-methyl-D-aspartate-preferring receptors.
    Johnson MD; Whetsell WO; Crowley WR
    Exp Brain Res; 1985; 59(1):57-61. PubMed ID: 2990984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinic acid stimulates luteinizing hormone secretion through a serotonin-dependent mechanism.
    Johnson MD; Carroll BL; Whetsell WO; Crowley WR
    Exp Brain Res; 1985; 59(1):62-7. PubMed ID: 2990985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.